Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC.ZBH · Entity 3278 | Group President, Asia Pacific | May 29, 2026 | June 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ZIMMER BIOMET HOLDINGS, INC.
Report date May 29, 2026 · Filed June 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 27,251 |
Ending reported balance
After 2026-05-29 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-29 · Sale · Disposed 4,200 · Balance 28,051 Row 2 · 2026-05-29 · Sale · Disposed 800 · Balance 27,251 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 07, 2020 Filed Jun 9, 2020 21:11 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 6,717 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-20-000129 · edgar.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,223 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 20:24 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 3,000 | $125.38 | $376,130.10 |
DisclosureSEC source: 0000911916-20-000115 · edgar.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,506 Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 20:48 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 2,208 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-20-000076 · edgar.xml · derivative · entry 2 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,208 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Zimmer Biomet Holdings, Inc.'s common stock. F2 · derivative.exercise_date: Earned RSUs vested on March 20, 2020. F2 · derivative.expiration_date: Earned RSUs vested on March 20, 2020. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 20:48 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 2,208 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-20-000076 · edgar.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,506 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 21:25 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 1,756 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-20-000061 · edgar.xml · derivative · entry 2 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,756 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: Earned RSUs vested on February 26, 2020. F3 · derivative.expiration_date: Earned RSUs vested on February 26, 2020. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 21:25 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 1,756 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-20-000061 · edgar.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,298 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 85 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan and pursuant to dividend reinvestment between November 4, 2019 and February 4, 2020. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:36 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 25,355 | $0.00 Strike: $157.54 | $0.00 |
DisclosureSEC source: 0000911916-20-000039 · edgar.xml · derivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,355 Underlying: Common Stock · 25,355 shares Expires 2030-02-21 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 21, 2021. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 23:02 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 1,756 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-20-000025 · edgar.xml · derivative · entry 2 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,756 Underlying: Common Stock · 1,756 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F4 · shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2019, the reporting person earned 1,756 RSUs. F5 · derivative.exercise_date: Earned RSUs will vest on February 26, 2020. F5 · derivative.expiration_date: Earned RSUs will vest on February 26, 2020. F4 · derivative.underlying_shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2019, the reporting person earned 1,756 RSUs. F4 · balance_after: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2019, the reporting person earned 1,756 RSUs. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 23:02 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 2,208 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-20-000025 · edgar.xml · derivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,208 Underlying: Common Stock · 2,208 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · shares: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2018-2019, the reporting person earned 2,208 RSUs. F3 · derivative.exercise_date: Earned RSUs will vest on March 20, 2020. F3 · derivative.expiration_date: Earned RSUs will vest on March 20, 2020. F2 · derivative.underlying_shares: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2018-2019, the reporting person earned 2,208 RSUs. F2 · balance_after: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2018-2019, the reporting person earned 2,208 RSUs. Read SEC document |
| August 08, 2019 Filed Aug 9, 2019 20:15 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 147 | $138.70 | $20,388.17 |
DisclosureSEC source: 0000911916-19-000158 · edgar.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,457 F1 · balance_after: Includes 147 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan on June 28, 2019. Read SEC document |
| May 24, 2019 Filed May 29, 2019 20:16 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 426 | $114.88 | $48,938.03 |
DisclosureSEC source: 0000911916-19-000122 · edgar.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,457 Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 20:15 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 1,443 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000084 · edgar.xml · derivative · entry 2 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,443 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: Earned RSUs vested on March 20, 2019. F3 · derivative.expiration_date: Earned RSUs vested on March 20, 2019. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 20:15 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 1,443 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000084 · edgar.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,883 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 426 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan between June 30, 2017 and December 31, 2018. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:33 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 26,116 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0000911916-19-000067 · edgar.xml · derivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,116 Underlying: Common Stock · 26,116 shares Expires 2029-02-26 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 26, 2020. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 21:31 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 1,443 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000038 · edgar.xml · derivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,443 Underlying: Common Stock · 1,443 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · shares: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 15, 2019, based on actual performance for 2018, the reporting person earned 1,443 RSUs. F3 · derivative.exercise_date: Earned RSUs will vest on March 20, 2019. F3 · derivative.expiration_date: Earned RSUs will vest on March 20, 2019. F2 · derivative.underlying_shares: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 15, 2019, based on actual performance for 2018, the reporting person earned 1,443 RSUs. F2 · balance_after: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 15, 2019, based on actual performance for 2018, the reporting person earned 1,443 RSUs. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 20:42 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 6,717 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-18-000129 · edgar.xml · derivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,717 Underlying: Common Stock · 6,717 shares Expires 2020-06-07 F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 20:13 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 24,075 | $0.00 Strike: $114.44 | $0.00 |
DisclosureSEC source: 0000911916-18-000073 · edgar.xml · derivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,075 Underlying: Common Stock · 24,075 shares Expires 2028-03-20 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on March 20, 2019. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:38 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 21,565 | $0.00 Strike: $119.61 | $0.00 |
DisclosureSEC source: 0000911916-18-000047 · edgar.xml · derivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,565 Underlying: Common Stock · 21,565 shares Expires 2028-02-20 Read SEC document |
| June 12, 2017 Filed Jun 13, 2017 21:20 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 4,300 | $123.62 | $531,547.51 |
DisclosureSEC source: 0000911916-17-000192 · edgar.xml · nonDerivative · entry 8 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14 F5 · price: Represents the sale of 4,300 shares in multiple transactions ranging in price from $123.415 to $123.72 per share, resulting in a weighted average sale price of $123.6157. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 21:20 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,310 | $0.00 Strike: $94.34 | $0.00 |
DisclosureSEC source: 0000911916-17-000192 · edgar.xml · derivative · entry 11 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,655 Underlying: Common Stock · 3,310 shares Expires 2024-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: 1,655 options vested on each of March 17, 2016 and 2017; and the remaining 1,655 of the options are scheduled to vest on March 17, 2018. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 21:20 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,550 | $0.00 Strike: $74.90 | $0.00 |
DisclosureSEC source: 0000911916-17-000192 · edgar.xml · derivative · entry 10 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,550 shares Expires 2023-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: 1,775 options vested on each of April 1, 2016 and 2017. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 21:20 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,097 | $0.00 Strike: $73.15 | $0.00 |
DisclosureSEC source: 0000911916-17-000192 · edgar.xml · derivative · entry 9 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,097 shares Expires 2023-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 3,049 options vested on March 18, 2016; and 3,048 options vested on March 18, 2017. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 21:20 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 474 | $124.93 | $59,216.87 |
DisclosureSEC source: 0000911916-17-000192 · edgar.xml · nonDerivative · entry 7 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,314 Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 21:20 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 3,310 | $124.86 | $413,299.84 |
DisclosureSEC source: 0000911916-17-000192 · edgar.xml · nonDerivative · entry 6 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,788 F4 · price: Represents the sale of 3,310 shares in multiple transactions ranging in price from $124.42 to $125.30 per share, resulting in a weighted average sale price of $124.864. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 21:20 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 3,550 | $124.86 | $443,257.97 |
DisclosureSEC source: 0000911916-17-000192 · edgar.xml · nonDerivative · entry 5 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,098 F3 · price: Represents the sale of 3,550 shares in multiple transactions ranging in price from $124.40 to $125.33 per share, resulting in a weighted average sale price of $124.8614. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 21:20 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 6,097 | $124.86 | $761,270.81 |
DisclosureSEC source: 0000911916-17-000192 · edgar.xml · nonDerivative · entry 4 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,648 F2 · price: Represents the sale of 6,097 shares in multiple transactions ranging in price from $124.40 to $125.33 per share, resulting in a weighted average sale price of $124.8599. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 21:20 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 3,310 | $94.34 | $312,265.40 |
DisclosureSEC source: 0000911916-17-000192 · edgar.xml · nonDerivative · entry 3 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,745 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 21:20 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 3,550 | $74.90 | $265,895.00 |
DisclosureSEC source: 0000911916-17-000192 · edgar.xml · nonDerivative · entry 2 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,435 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 21:20 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 6,097 | $73.15 | $445,995.55 |
DisclosureSEC source: 0000911916-17-000192 · edgar.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,885 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1 share acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan on May 1, 2017 and 6 shares purchased on April 28, 2017 under the dividend reinvestment plan for the Company's common stock. Read SEC document |
| April 01, 2017 Filed Apr 4, 2017 19:01 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-17-000137 · edgar.xml · derivative · entry 2 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: The RSUs vested on April 1, 2017. F2 · derivative.expiration_date: The RSUs vested on April 1, 2017. Read SEC document |
| April 01, 2017 Filed Apr 4, 2017 19:01 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-17-000137 · edgar.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,781 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 21:04 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 21,322 | $0.00 Strike: $121.88 | $0.00 |
DisclosureSEC source: 0000911916-17-000133 · edgar.xml · derivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,322 Underlying: Common Stock · 21,322 shares Expires 2027-03-21 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on March 21, 2018. Read SEC document |
| March 17, 2017 Filed Mar 21, 2017 19:06 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 1,197 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-17-000111 · edgar.xml · derivative · entry 2 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,197 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F3 · derivative.exercise_date: The earned RSUs vested on March 17, 2017. F3 · derivative.expiration_date: The earned RSUs vested on March 17, 2017. Read SEC document |
| March 17, 2017 Filed Mar 21, 2017 19:06 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 1,197 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-17-000111 · edgar.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,381 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 244 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan between May 2, 2016 and January 30, 2017 and 8 shares purchased between October 28, 2016 and January 27, 2017 under the dividend reinvestment plan for the Company's common stock. Read SEC document |
| February 09, 2017 Filed Feb 13, 2017 19:56 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 1,197 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-17-000062 · edgar.xml · derivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,197 Underlying: Common Stock · 1,197 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · shares: On March 17, 2014, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2014 - 2016. As determined on February 9, 2017, based on the Company's actual performance for 2014 - 2016, the reporting person earned 1,197 RSUs. F3 · derivative.exercise_date: Earned RSUs will vest on March 17, 2017. F3 · derivative.expiration_date: Earned RSUs will vest on March 17, 2017. F2 · derivative.underlying_shares: On March 17, 2014, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2014 - 2016. As determined on February 9, 2017, based on the Company's actual performance for 2014 - 2016, the reporting person earned 1,197 RSUs. F2 · balance_after: On March 17, 2014, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2014 - 2016. As determined on February 9, 2017, based on the Company's actual performance for 2014 - 2016, the reporting person earned 1,197 RSUs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.